TLR4使等离子体细胞状树突细胞对抗SARS-CoV-2冠状病毒的抗病毒反应敏感

King Hoo Lim1, Lishi Wang2, Eunice Dotse1

  • 1Department of Biomedical Sciences, City University of Hong Kong, 83 Tat Chee Ave, Kowloon Tong, Kowloon, Hong Kong.

Journal of leukocyte biology
|September 25, 2023
PubMed
概括

收费类受体4 (TLR4) 与TLR7/8类似地激活血类树突细胞,增强抗病毒反应和针对SARS-CoV-2的I型干扰素产生. 这揭示了治疗潜力的独特TLR4激活通路.